Peter Bisgaard

Peter Bisgaard

Voorzitter bij
Engrail Therapeutics, Inc.
52 jaar
Health Technology
Finance
Commercial Services

Profiel

Peter Tuxen Bisgaard is currently the Chairman at Oncxerna Therapeutics, Inc. and Engrail Therapeutics, Inc. He is also the Managing Director at Novo Ventures 1 A, the Director at The Outpost Ltd., and the Managing Director at Nan Fung Life Sciences.
Additionally, he is the Managing Partner at Pivotal Bioventure Partners Investment Advisor LLC since 2017.
In his former positions, Mr. Bisgaard served as the Chairman at HTG Molecular Diagnostics, Inc. from 2015 to 2017.
He was also the Chairman at Neurokey A and Otonomy, Inc. from 2013 to 2015.
Furthermore, he held the role of Independent Director at Ra Pharmaceuticals, Inc. from 2015 to 2019.
He has also served as an Independent Non-Executive Director at Eargo, Inc. from 2017 to 2022.
Additionally, he held various director positions at Light Sciences Oncology, Inc., Asante Solutions, Inc., Thesan Pharmaceuticals, Inc., Azanta Danmark A, Lundbeck Seattle BioPharmaceuticals, Inc., Nevro Corp., Hemofocus ApS, Altheos, Inc., Ceterix Orthopaedics, Inc., Bolt Biotherapeutics, Inc., Entasis Therapeutics, Inc., Chromaderm, Inc., Outpost Medicine, Inc., and Inozyme Pharma, Inc. He was also a Principal at McKinsey & Co., Inc. and a Senior Partner at Novo Holdings AS (Denmark) from 2009 to 2017.
Mr. Bisgaard obtained his graduate degree from the Technical University of Denmark in 1998.

Actieve functies van Peter Bisgaard

BedrijvenFunctieBegin
Directeur/Bestuurslid -
Private Equity Investor 01-09-2017
Voorzitter -
Voorzitter -
Private Equity Investor -

Eerdere bekende functies van Peter Bisgaard

BedrijvenFunctieEinde
EARGO, INC. Directeur/Bestuurslid 03-08-2022
RA PHARMACEUTICALS, INC. Directeur/Bestuurslid 11-06-2019
HTG MOLECULAR DIAGNOSTICS, INC. Voorzitter 07-03-2017
Corporate Officer/Principal 01-01-2017
░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Peter Bisgaard in detail bekijken

Opleiding van Peter Bisgaard

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

62

Eerstegraads connecties

28

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit28

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Transportation

Health Technology

Finance

Finance

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Peter Bisgaard
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU